Hisamitsu Pharmaceutical’s ¥457 billion plan to go private is being seen as a prime example of a flight from public markets among Japan’s drugmakers, with analysts expecting more to follow.
Uncategorized
1
Posts
1
Posters
0
Views
-
Hisamitsu Pharmaceutical’s ¥457 billion plan to go private is being seen as a prime example of a flight from public markets among Japan’s drugmakers, with analysts expecting more to follow. https://www.japantimes.co.jp/business/2026/01/08/companies/buyout-wave-seen-among-japanese-drugmakers/?utm_medium=Social&utm_source=mastodon #business #companies #hisamitsu #salonpas #pharmaceuticals #acquisitions #stocks #tse #pharmaceuticals #health #medicine
-
T #medicine shared this topic